Diamedica Therapeutics Inc. (DMAC)

Market is closed

Sector: Pharmaceutical Preparations

Hedge Fund Popularity

Display

Display Share Price

Hedge Fund Holdings

Filing Period:

Last updated on August 15, 2025, 9:10am based on SEC 13F filings Last update: August 15, 2025, 9:10am

No.	Hedge Fund	Shares	Value	Activity	% Port
1.	Omega Advisors Leon Cooperman	1,650,000	$6,435,000	+2%	0.23%
2.	Marshall Wace LLP Paul Marshall And Ian Wace	61,719	$240,705	+228%	0%
3.	Millennium Management Israel Englander	0	$0		0%
4.	Jain Global LLC Bobby Jain	0	$0		0%
5.	Point72 (DIFC) Ltd Steve Cohen	0	$0		0%

Insider Trading: Purchases See All

Insider	Price	Amount	Total Value	Remaining Holdings	Date	Form 4
Stahlberg Large Shareholder	$3.50	1,542,857	$5,399,999.50	6,764,465	2025-07-23	Filing
Von Large Shareholder	$3.50	2,857,142	$9,999,997.00	8,383,577	2025-07-23	Filing
Jacinto Large Shareholder	$3.50	400,000	$1,400,000.00	4,958,823	2025-07-23	Filing
Von Large Shareholder	$2.50	1,200,000	$3,000,000.00	5,526,435	2024-06-28	Filing
Stahlberg Large Shareholder	$2.50	1,200,000	$3,000,000.00	5,221,608	2024-06-28	Filing

Insider Trading: Sales See All

Insider	Price	Amount	Total Value	Remaining Holdings	Date	Form 4
Von Large Shareholder	$1.24	2,855,847	$3,526,971.05	0	2022-12-02	Filing

Institutional Investors' Holdings

Filing Period:

No.	Name	Shares	Value	% Port
1.	Vanguard Group Inc	1,535,054	$5,986,711	0%
2.	Blackrock, Inc.	1,191,813	$4,648,071	0%
3.	Paragon Associates & Paragon Associates Ii Joint Venture	650,000	$2,535,000	4.03%
4.	Geode Capital Management, Llc	630,148	$2,457,806	0%
5.	First Manhattan Co	606,435	$2,365,097	0.01%